Quantitative Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,706
Closed -$241K 482
2024
Q4
$241K Buy
+6,706
New +$227K 0.02% 305
2022
Q1
Sell
-9,548
Closed -$1.44M 322
2021
Q4
$1.44M Sell
9,548
-10,057
-51% -$1.36M 0.2% 98
2021
Q3
$2.34M Buy
+19,605
New +$2.16M 0.21% 104

Other funds holding TNDM

Quantitative Investment Management's TNDM Position: Q1 2025 in Review

Quantitative Investment Management sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 6,706 shares — an estimated $241K sold.

Quantitative Investment Management first reported a position in TNDM in Q3 2021 and held it in 3 quarters. The position peaked at $2.34M in Q3 2021. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • Quantitative Investment Management reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • Quantitative Investment Management sold 6,706 Tandem Diabetes Care shares in Q1 2025, an estimated $241K.
  • Quantitative Investment Management first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 3 quarters.
  • Quantitative Investment Management's Tandem Diabetes Care position peaked at $2.34M in Q3 2021.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Quantitative Investment Management's 13F filing for Q1 2025, filed 14 May 2025.